Summary:
Sexual Dysfunction after Childbirth Study
It’s not bad, it’s just not the same.
The VIVEVE II study is a clinical trial evaluating the Geneveve Treatment as an investigational treatment for female sexual dysfunction. This is not a commercial treatment.
Qualified Participants Must:
• Geneveve is being evaluated as a treatment for women who are having decreased sexual experiences after childbirth, including problems with arousal, desire, lubrication, orgasm and pain during sex
Qualified Participants May Receive:
Qualified participants may receive:
- Geneveve Treatment or placebo treatment at no cost
- Compensation for time and travel
- Study related care from a board-certified physician at no cost